Incyte Historical Income Statement

INCY Stock

USD 74.95 0.31 0.41%

Historical analysis of Incyte income statement accounts such as Total Revenue of 4.5 B or Gross Profit of 4.2 B can show how well Incyte performed in making a profits. Evaluating Incyte income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Incyte's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Incyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Incyte is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

About Incyte Income Statement Analysis

Incyte Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Incyte shareholders. The income statement also shows Incyte investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Incyte Income Statement Chart

At this time, Incyte's Total Other Income Expense Net is fairly stable compared to the past year. Net Income is likely to rise to about 721.6 M in 2025, whereas Interest Expense is likely to drop slightly above 2.8 M in 2025.

Depreciation And Amortization Gross Profit Ebit Ebitda Total Other Income Expense Net Research Development

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Incyte minus its cost of goods sold. It is profit before Incyte operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Incyte's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Total Other Income Expense Net is fairly stable compared to the past year. Net Income is likely to rise to about 721.6 M in 2025, whereas Interest Expense is likely to drop slightly above 2.8 M in 2025.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	2.6B	2.8B	3.2B	3.4B
Cost Of Revenue	207.0M	255M	293.3M	307.9M

Total Operating Expenses Cost Of Revenue

Incyte income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Selling General Administrative	Extraordinary Items	Net Income From Continuing Ops	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Selling And Marketing Expenses
Depreciation And Amortization		-0.46	0.91	0.91	0.89	0.77	0.81	0.83	0.75	0.88	0.81	0.74	0.69	0.55	0.81	0.91	0.55	0.67	0.61	0.52	0.7	0.83	0.72	0.72
Interest Expense	-0.46		-0.7	-0.7	-0.72	-0.48	-0.5	-0.5	-0.5	-0.72	-0.51	-0.4	-0.49	-0.23	-0.74	-0.62	0.17	-0.42	-0.43	-0.2	-0.34	-0.56	-0.45	-0.33
Total Revenue	0.91	-0.7		1.0	0.99	0.81	0.84	0.85	0.81	0.98	0.84	0.72	0.74	0.5	0.92	0.98	0.35	0.7	0.65	0.46	0.66	0.86	0.77	0.7
Gross Profit	0.91	-0.7	1.0		0.99	0.8	0.84	0.85	0.81	0.98	0.83	0.72	0.74	0.49	0.93	0.97	0.36	0.7	0.65	0.45	0.66	0.86	0.77	0.69
Other Operating Expenses	0.89	-0.72	0.99	0.99		0.7	0.75	0.76	0.8	1.0	0.74	0.68	0.64	0.5	0.97	0.95	0.37	0.59	0.59	0.47	0.61	0.84	0.72	0.66
Operating Income	0.77	-0.48	0.81	0.8	0.7		0.98	0.98	0.68	0.69	0.98	0.71	0.96	0.38	0.53	0.86	0.21	0.91	0.74	0.34	0.71	0.73	0.78	0.68
Ebit	0.81	-0.5	0.84	0.84	0.75	0.98		1.0	0.75	0.73	1.0	0.82	0.93	0.48	0.58	0.9	0.21	0.86	0.74	0.44	0.82	0.84	0.84	0.8
Ebitda	0.83	-0.5	0.85	0.85	0.76	0.98	1.0		0.76	0.75	1.0	0.82	0.93	0.49	0.6	0.91	0.23	0.86	0.74	0.45	0.82	0.84	0.84	0.81
Cost Of Revenue	0.75	-0.5	0.81	0.81	0.8	0.68	0.75	0.76		0.79	0.74	0.69	0.61	0.52	0.7	0.85	0.33	0.54	0.59	0.51	0.71	0.81	0.75	0.73
Total Operating Expenses	0.88	-0.72	0.98	0.98	1.0	0.69	0.73	0.75	0.79		0.73	0.67	0.63	0.49	0.98	0.94	0.38	0.58	0.58	0.46	0.59	0.83	0.71	0.65
Income Before Tax	0.81	-0.51	0.84	0.83	0.74	0.98	1.0	1.0	0.74	0.73		0.82	0.93	0.47	0.58	0.89	0.2	0.87	0.76	0.43	0.81	0.82	0.82	0.79
Total Other Income Expense Net	0.74	-0.4	0.72	0.72	0.68	0.71	0.82	0.82	0.69	0.67	0.82		0.65	0.67	0.55	0.78	0.16	0.52	0.68	0.63	0.94	0.9	0.77	0.94
Net Income	0.69	-0.49	0.74	0.74	0.64	0.96	0.93	0.93	0.61	0.63	0.93	0.65		0.13	0.49	0.77	0.17	0.98	0.66	0.09	0.61	0.65	0.67	0.6
Income Tax Expense	0.55	-0.23	0.5	0.49	0.5	0.38	0.48	0.49	0.52	0.49	0.47	0.67	0.13		0.4	0.58	0.13	-0.01	0.48	1.0	0.74	0.67	0.63	0.71
Research Development	0.81	-0.74	0.92	0.93	0.97	0.53	0.58	0.6	0.7	0.98	0.58	0.55	0.49	0.4		0.84	0.37	0.47	0.5	0.37	0.45	0.73	0.58	0.5
Selling General Administrative	0.91	-0.62	0.98	0.97	0.95	0.86	0.9	0.91	0.85	0.94	0.89	0.78	0.77	0.58	0.84		0.33	0.7	0.64	0.55	0.76	0.91	0.85	0.8
Extraordinary Items	0.55	0.17	0.35	0.36	0.37	0.21	0.21	0.23	0.33	0.38	0.2	0.16	0.17	0.13	0.37	0.33		0.26	0.16	0.13	0.17	0.26	0.39	0.19
Net Income From Continuing Ops	0.67	-0.42	0.7	0.7	0.59	0.91	0.86	0.86	0.54	0.58	0.87	0.52	0.98	-0.01	0.47	0.7	0.26		0.62	-0.05	0.47	0.53	0.57	0.45
Non Operating Income Net Other	0.61	-0.43	0.65	0.65	0.59	0.74	0.74	0.74	0.59	0.58	0.76	0.68	0.66	0.48	0.5	0.64	0.16	0.62		0.47	0.61	0.53	0.57	0.5
Tax Provision	0.52	-0.2	0.46	0.45	0.47	0.34	0.44	0.45	0.51	0.46	0.43	0.63	0.09	1.0	0.37	0.55	0.13	-0.05	0.47		0.72	0.64	0.6	0.68
Interest Income	0.7	-0.34	0.66	0.66	0.61	0.71	0.82	0.82	0.71	0.59	0.81	0.94	0.61	0.74	0.45	0.76	0.17	0.47	0.61	0.72		0.91	0.8	0.96
Net Interest Income	0.83	-0.56	0.86	0.86	0.84	0.73	0.84	0.84	0.81	0.83	0.82	0.9	0.65	0.67	0.73	0.91	0.26	0.53	0.53	0.64	0.91		0.85	0.95
Reconciled Depreciation	0.72	-0.45	0.77	0.77	0.72	0.78	0.84	0.84	0.75	0.71	0.82	0.77	0.67	0.63	0.58	0.85	0.39	0.57	0.57	0.6	0.8	0.85		0.82
Selling And Marketing Expenses	0.72	-0.33	0.7	0.69	0.66	0.68	0.8	0.81	0.73	0.65	0.79	0.94	0.6	0.71	0.5	0.8	0.19	0.45	0.5	0.68	0.96	0.95	0.82

Click cells to compare fundamentals

Incyte Account Relationship Matchups

Incyte income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	51.8M	57.8M	67.9M	82.7M	95.1M	99.8M
Interest Expense	2.2M	1.9M	2.7M	2.6M	2.9M	2.8M
Total Revenue	2.7B	3.0B	3.4B	3.7B	4.2B	4.5B
Gross Profit	2.5B	2.8B	3.2B	3.4B	4.0B	4.2B
Other Operating Expenses	2.9B	2.4B	2.8B	3.1B	3.5B	3.7B
Operating Income	(240.3M)	585.8M	579.4M	620.5M	713.6M	749.3M
Ebit	(230.0M)	572.4M	531.8M	836.8M	962.3M	1.0B
Ebitda	(178.2M)	630.2M	599.6M	919.4M	1.1B	1.1B
Cost Of Revenue	131.3M	151.0M	207.0M	255M	293.3M	307.9M
Total Operating Expenses	2.8B	2.2B	2.6B	2.8B	3.2B	3.4B
Income Before Tax	(232.2M)	570.4M	529.1M	834.2M	959.3M	1.0B
Total Other Income Expense Net	31.5M	(15.3M)	(50.3M)	213.7M	245.7M	258.0M
Net Income	(295.7M)	948.6M	340.7M	597.6M	687.2M	721.6M
Income Tax Expense	63.5M	(378.1M)	188.5M	236.6M	272.1M	285.7M
Research Development	2.2B	1.5B	1.6B	1.6B	1.9B	2.0B
Selling General Administrative	516.9M	739.6M	1.0B	1.2B	1.3B	1.4B
Net Income From Continuing Ops	(295.7M)	948.6M	340.7M	425.0M	488.7M	513.2M
Non Operating Income Net Other	52.2M	23.2M	10.6M	39.9M	45.9M	48.2M
Net Income Applicable To Common Shares	446.9M	(295.7M)	948.6M	340.7M	391.8M	411.3M
Tax Provision	63.5M	(378.1M)	188.5M	218.9M	251.7M	264.3M
Net Interest Income	(2.2M)	(1.9M)	(2.7M)	106.2M	122.1M	128.2M
Reconciled Depreciation	51.8M	57.8M	67.9M	79.1M	91.0M	65.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GM	General Motors
C	Citigroup

Additional Tools for Incyte Stock Analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incyte Historical Income Statement

About Incyte Income Statement Analysis

Incyte Income Statement Chart

Depreciation And Amortization

Gross Profit

Incyte income statement Correlations

Incyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incyte income statement Accounts

Also Currently Popular

Additional Tools for Incyte Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebitda
Tax Provision	+ 1.0	Income Tax Expense

Research Development	- 0.74	Interest Expense
Total Operating Expenses	- 0.72	Interest Expense
Other Operating Expenses	- 0.72	Interest Expense
Gross Profit	- 0.7	Interest Expense
Total Revenue	- 0.7	Interest Expense
Selling General Administrative	- 0.62	Interest Expense